An alternative mechanism of linc00261 activity in pancreatic cancer is via targeting of miR-222-3, leading to the modulation of MYC expression both via miRNA regulation and sequestration of insulin-like growth factor 2 mRNA binding protein 1 (IGF2BP1). The gene discussed is MYC; the disease is familial pancreatic carcinoma.